These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23697579)

  • 41. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
    Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimuli-responsive hollow polymer nanoparticles for use as novel delivery systems.
    Kim JH; Burnett RD; Gabriel A
    J Biomed Nanotechnol; 2012 Jun; 8(3):432-8. PubMed ID: 22764412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and release characteristic of quercetin loaded poly(lactic acid) ultrafine fibers.
    Peng J; Qian Z; Wang B; Fu S; Guo G; Luo F; Li R; Wu D
    J Nanosci Nanotechnol; 2011 Apr; 11(4):3659-68. PubMed ID: 21776751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
    Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
    Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures.
    Biondi M; Guarnieri D; Yu H; Belli V; Netti PA
    Nanotechnology; 2013 Feb; 24(4):045101. PubMed ID: 23293277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
    Rangger C; Helbok A; von Guggenberg E; Sosabowski J; Radolf T; Prassl R; Andreae F; Thurner GC; Haubner R; Decristoforo C
    Int J Nanomedicine; 2012; 7():5889-900. PubMed ID: 23226020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery.
    Yang YQ; Zhao B; Li ZD; Lin WJ; Zhang CY; Guo XD; Wang JF; Zhang LJ
    Acta Biomater; 2013 Aug; 9(8):7679-90. PubMed ID: 23669619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.
    Miller MA; Gadde S; Pfirschke C; Engblom C; Sprachman MM; Kohler RH; Yang KS; Laughney AM; Wojtkiewicz G; Kamaly N; Bhonagiri S; Pittet MJ; Farokhzad OC; Weissleder R
    Sci Transl Med; 2015 Nov; 7(314):314ra183. PubMed ID: 26582898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
    Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
    J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.
    Liu CW; Lin WJ
    Int J Nanomedicine; 2012; 7():4749-67. PubMed ID: 22973097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and biodistribution of a theranostic aluminum phthalocyanine nanophotosensitizer.
    Asem H; El-Fattah AA; Nafee N; Zhao Y; Khalil L; Muhammed M; Hassan M; Kandil S
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():48-57. PubMed ID: 26708297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy.
    Saw PE; Yu M; Choi M; Lee E; Jon S; Farokhzad OC
    Biomaterials; 2017 Apr; 123():118-126. PubMed ID: 28167390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Encapsulation of the antimicrobial and immunomodulator agent nitazoxanide within polymeric micelles.
    Glisoni RJ; Sosnik A
    J Nanosci Nanotechnol; 2014 Jun; 14(6):4670-82. PubMed ID: 24738446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interfacially assembled carbohydrate nanocapsules: a hydrophilic macromolecule delivery platform.
    Sarkar AB; Kestur U; Kochak GM
    J Biomed Nanotechnol; 2009 Oct; 5(5):456-63. PubMed ID: 20201418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.